Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide. 2007

Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
Division of Hematology, Catholic Hematopoietic Stem Cell Transplantation Center, The Catholic University of Korea, Seoul, Korea.

The outcome of unrelated donor bone marrow transplantation for aplastic anemia is inferior to that of sibling donor bone marrow transplantation because of a higher rate of transplant-related mortality (TRM), which is closely associated with the intensity of pretransplant conditioning to overcome graft rejection. We conducted a prospective trial with an intermediate to high dose of total body irradiation (TBI) in combination with a fixed dose of cyclophosphamide (120 mg/kg) to use for pretransplant conditioning for unrelated donor bone marrow transplantation in adult aplastic anemia. The number of patients who received doses of 1200, 1000, and 800 cGy of TBI were 5, 9, and 26, respectively. The corresponding probabilities of overall survival (OS) at 3 years were 40%, 44%, and 92%, respectively. The incidence of regimen-related toxicity with grade III-IV and graft rejection in the patients who received a dose of 800 cGy of TBI were 0 of 26 patients. The significant factors associated with OS were the TBI dose (800 cGy vs. >or=1000 cGy; P = .001), chronic graft-versus-host disease (less than or equal to limited vs. extensive; P = .013), the method of HLA typing for the donor-recipient matching (serologic typing vs. DNA-based typing; P = .006), and the transfusion amount before transplantation (<or=90 vs. >90 units; P = .020).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
January 1995, Blood,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
January 1992, Bone marrow transplantation,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
January 1989, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
September 1983, Blood,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
June 1987, La Radiologia medica,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
September 2001, British journal of haematology,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
January 1980, Haematology and blood transfusion,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
December 2004, Bone marrow transplantation,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
March 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Sung-Yong Kim, and Jong-Wook Lee, and Jihyang Lim, and Byung-Sik Cho, and Ki-Seong Eom, and Yoo-Jin Kim, and Hee-Je Kim, and Seok Lee, and Chang-Ki Min, and Seok-Goo Cho, and Dong-Wook Kim, and Woo-Sung Min, and Chun-Choo Kim
January 1984, Progress in clinical and biological research,
Copied contents to your clipboard!